Format

Send to

Choose Destination
See comment in PubMed Commons below
FEBS Lett. 2010 Jun 18;584(12):2670-80. doi: 10.1016/j.febslet.2010.04.014. Epub 2010 Apr 11.

Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.

Author information

1
Department of Molecular Biotechnology, School of Biotechnology, Royal Institute of Technology (KTH), AlbaNova University Center, Stockholm, Sweden.

Abstract

Affibody molecules are a class of engineered affinity proteins with proven potential for therapeutic, diagnostic and biotechnological applications. Affibody molecules are small (6.5 kDa) single domain proteins that can be isolated for high affinity and specificity to any given protein target. Fifteen years after its discovery, the Affibody technology is gaining use in many groups as a tool for creating molecular specificity wherever a small, engineering compatible tool is warranted. Here we summarize recent results using this technology, propose an Affibody nomenclature and give an overview of different HER2-specific Affibody molecules. Cumulative evidence suggests that the three helical scaffold domain used as basis for these molecules is highly suited to create a molecular affinity handle for vastly different applications.

PMID:
20388508
DOI:
10.1016/j.febslet.2010.04.014
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center